| EPA094 | Characterization of serum and mucosal SARS-CoV-2-antibodies in HIV-1 infected subjects after BNT162b2 mRNA vaccination or SARS-CoV-2 infection | E-poster | SARS-Cov2 vaccines |
| PEMOA33 | Serological responses to SARS-CoV2 vaccination in people with HIV: the SCAPE-HIV study | Poster exhibition | SARS-Cov2 vaccines |
| PEMOA35 | Side-by-side comparison of SARS-CoV-2 neutralizing antibody responses after various COVID-19 vaccine regimens | Poster exhibition | SARS-Cov2 vaccines |
| PEMOA36 | Immunogenicity of the BNT 162b2 mRNA vaccine against COVID-19 variants in people living with HIV on antiretroviral therapy in Malaysia | Poster exhibition | SARS-Cov2 vaccines |
| PEMOA37 | Vaccine scheme, age and previous COVID-19 predict humoral response to SARS-CoV-2 vaccination in HIV-infected indivudals | Poster exhibition | SARS-Cov2 vaccines |
| PEMOA38 | People living with HIV who are receiving suppressive antiretroviral therapy mount strong humoral responses to two and three doses of COVID-19 vaccine | Poster exhibition | SARS-Cov2 vaccines |
| EPF048 | Healthcare and social assistance for the social protection of people with HIV/AIDS in situations of vulnerability: the Brazilian case | E-poster | Safe housing, social protection and other care and support for people affected by HIV |
| EPD042 | Factors associated with viral non-suppression among HIV positive children and adolescents enrolled to the orphans and vulnerable program in Uganda | E-poster | Role of social and behavioural science in biomedical responses |
| EPD043 | Three-year follow-up of PositiveLinks: higher use of mHealth platform associated with sustained viral suppression | E-poster | Role of social and behavioural science in biomedical responses |
| PEMOD75 | PrEParados: a spatially explicit network visualization framework to identify Latino MSM who qualify for PrEP use | Poster exhibition | Role of social and behavioural science in biomedical responses |